Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: Verdict 2

Charles A. Herzog

doi:10.2215/CJN.09470916

Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: Verdict 2

Charles A. Herzog

Medicine - Cardiology Division

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	2095-2096
Number of pages	2
Journal	Clinical Journal of the American Society of Nephrology
Volume	11
Issue number	11
DOIs	https://doi.org/10.2215/CJN.09470916
State	Published - 2016

Bibliographical note

Funding Information:
This work was supported by the Chronic Disease Research Group, Minneapolis Medical Research Foundation.

Keywords

Anticoagulants
Atrial fibrillation
Blood Coagulation
Disease Management
Humans
Kidney Failure, Chronic
end-stage renal disease

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.2215/CJN.09470916

Find It

Find It at U of M Libraries

Cite this

@article{2ffc063c00284468af71c173e8a57df9,

title = "Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: Verdict 2",

keywords = "Anticoagulants, Atrial fibrillation, Blood Coagulation, Disease Management, Humans, Kidney Failure, Chronic, end-stage renal disease",

author = "Herzog, \{Charles A.\}",

note = "Funding Information: This work was supported by the Chronic Disease Research Group, Minneapolis Medical Research Foundation.",

year = "2016",

doi = "10.2215/CJN.09470916",

language = "English (US)",

volume = "11",

pages = "2095--2096",

journal = "Clinical Journal of the American Society of Nephrology",

issn = "1555-9041",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD

T2 - Verdict 2

AU - Herzog, Charles A.

N1 - Funding Information: This work was supported by the Chronic Disease Research Group, Minneapolis Medical Research Foundation.

PY - 2016

Y1 - 2016

KW - Anticoagulants

KW - Atrial fibrillation

KW - Blood Coagulation

KW - Disease Management

KW - Humans

KW - Kidney Failure, Chronic

KW - end-stage renal disease

UR - https://www.scopus.com/pages/publications/85019963146

UR - https://www.scopus.com/pages/publications/85019963146#tab=citedBy

U2 - 10.2215/CJN.09470916

DO - 10.2215/CJN.09470916

M3 - Comment/debate

C2 - 27797902

AN - SCOPUS:85019963146

SN - 1555-9041

VL - 11

SP - 2095

EP - 2096

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

IS - 11

ER -

Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: Verdict 2

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Cite this